.Pharmacolibrary.Drugs.S_SensoryOrgans.S03A_Antiinfectives.S03AA07_Ciprofloxacin.Ciprofloxacin .Pharmacolibrary.Drugs.S_SensoryOrgans.S03A_Antiinfectives.S03AA07_Ciprofloxacin.Ciprofloxacin| name: | Ciprofloxacin |
| ATC code: | S03AA07 | route: | oral |
| n-compartments | 2 |
Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic used to treat a variety of bacterial infections including those of the urinary tract, respiratory tract, gastrointestinal system, skin, and eyes. It acts by inhibiting bacterial DNA gyrase and topoisomerase IV. Ciprofloxacin remains approved and widely used today for many infections sensitive to its action.
Pharmacokinetic parameters reported in healthy adult volunteers following a single oral dose.
Hirt, D, et al., & Benaboud, S (2021). Population pharmacokinetics of intravenous and oral ciprofloxacin in children to optimize dosing regimens. European journal of clinical pharmacology 77(11) 1687–1695. DOI:10.1007/s00228-021-03174-1 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34160669
Zahr, N, et al., & Funck-Brentano, C (2021). Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infections. The Journal of antimicrobial chemotherapy 76(11) 2906–2913. DOI:10.1093/jac/dkab275 PUBMED:https://pubmed.ncbi.nlm.nih.gov/34363656
Junkert, AM, et al., & Pontarolo, R (2024). Pharmacokinetics of oral ciprofloxacin in adult patients: A scoping review. British journal of clinical pharmacology 90(2) 528–547. DOI:10.1111/bcp.15933 PUBMED:https://pubmed.ncbi.nlm.nih.gov/37850318